Skip to main content
Uflex Limited logo

Uflex Limited — Investor Relations & Filings

Ticker · UFLEX ISIN · INE516A01017 LEI · 335800ARUS3DNRES4594 BSE.NS Manufacturing
Open in API
Filings indexed 1,700 across all filing types
Latest filing 2026-05-26 Regulatory Filings
Country IN India
Listing BSE.NS UFLEX

About Uflex Limited

https://www.uflexltd.com/

Uflex Limited is a vertically integrated provider of flexible packaging solutions, operating across the entire value chain. The company manufactures a diverse range of packaging films, including BOPET, BOPP, and CPP, as well as flexible packaging materials such as laminates, pouches, and bags. Its product portfolio includes aseptic liquid packaging, chemicals like inks and adhesives, and engineering solutions for packaging machinery. Additionally, the company produces cylinders and holography products for brand protection. Uflex serves global markets in sectors such as FMCG, food and beverage, pharmaceuticals, and personal care. The organization focuses on technological innovation and sustainable packaging developments, maintaining a comprehensive infrastructure for film production, converting, and recycling.

Recent filings

Filing Released Lang Actions
Intimation of Company's participation in 'Goldman Sachs: India Supply Chain Resilience Corporate Days' Meeting
Regulatory Filings Classification · 93% confidence The document is a regulatory disclosure under SEBI Listing Regulations, notifying stock exchanges of the company’s participation in an investor conference. It does not contain financial results, voting outcomes, board changes, or a full report; nor is it an actual investor presentation or earnings release. It is a general compliance announcement, which falls under the fallback category of Regulatory Filings (RNS).
2026-05-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 78% confidence The document is a short SEBI Listing Regulation 30 disclosure (intimation) regarding the company’s participation in an investor meeting/conference. It does not contain financial results, board or management changes, capital transactions, or AGM materials. It is an ongoing regulatory announcement/disclosure under continuous listing obligations. It therefore falls into the general Regulatory Filings category (RNS).
2026-05-26 English
Intimation of Earnings Conference Call under the SEBI (Listing Obligations and Disclosure Requirements), Regulations, 2015
Regulatory Filings Classification · 85% confidence The document is an intimation letter to stock exchanges under SEBI regulations, announcing the schedule and dial-in details for the Q4 & FY26 Earnings Conference Call. It contains no financial results, analysis, or transcripts—only notice of the call. It is neither an earnings release (no results presented) nor a call transcript (no Q&A). It is a general regulatory announcement required under listing obligations. Therefore, the correct category is Regulatory Filings (RNS).
2026-05-26 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 90% confidence The document is a formal intimation sent to stock exchanges under SEBI Listing Obligations announcing the Q4 & FY26 Earnings Conference Call schedule and dial-in details. It contains no financial data or transcript but is a regulatory announcement of an upcoming event. It does not constitute an earnings release (no results), financial report, or call transcript. Therefore, it falls under General Regulatory Filings.
2026-05-26 English
Uflex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve the Standalone & Consolidated Audited ....
Regulatory Filings Classification · 55% confidence The document is an exchange filing under SEBI LODR informing stock exchanges about the postponement and rescheduling of the Board Meeting. It does not contain actual financial results, board changes, or management data, nor is it the report itself. It is a routine regulatory announcement that does not fit other specific categories, so it falls under the general Regulatory Filings category (RNS).
2026-05-14 English
Uflex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 20/05/2026 ,inter alia, to consider and approve the Standalone & Consolidated Audited ....
Regulatory Filings Classification · 80% confidence The document is a short stock-exchange filing informing investors of an upcoming Board of Directors meeting date and agenda (e.g., for approving audited financial statements and recommending dividends). It does not itself contain financial statements or results, nor does it announce a management change, a dividend declaration, or publish a report. It is a routine regulatory notice to the exchanges, which falls under the miscellaneous regulatory announcements category. Therefore, it should be classified as a Regulatory Filings (RNS) submission.
2026-05-12 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.